Literature DB >> 29507146

β-Secretase BACE1 Promotes Surface Expression and Function of Kv3.4 at Hippocampal Mossy Fiber Synapses.

Stephanie Hartmann1,2, Fang Zheng1, Michele C Kyncl1, Sandra Karch1, Kerstin Voelkl1, Benedikt Zott3, Carla D'Avanzo2, Selene Lomoio4, Giuseppina Tesco4, Doo Y Kim2, Christian Alzheimer5, Tobias Huth5.   

Abstract

The β-secretase β-site APP-cleaving enzyme 1 (BACE1) is deemed a major culprit in Alzheimer's disease, but accumulating evidence indicates that there is more to the enzyme than driving the amyloidogenic processing of the amyloid precursor protein. For example, BACE1 has emerged as an important regulator of neuronal activity through proteolytic and, most unexpectedly, also through nonproteolytic interactions with several ion channels. Here, we identify and characterize the voltage-gated K+ channel 3.4 (Kv3.4) as a new and functionally relevant interaction partner of BACE1. Kv3.4 gives rise to A-type current with fast activating and inactivating kinetics and serves to repolarize the presynaptic action potential. We found that BACE1 and Kv3.4 are highly enriched and remarkably colocalized in hippocampal mossy fibers (MFs). In BACE1-/- mice of either sex, Kv3.4 surface expression was significantly reduced in the hippocampus and, in synaptic fractions thereof, Kv3.4 was specifically diminished, whereas protein levels of other presynaptic K+ channels such as KCa1.1 and KCa2.3 remained unchanged. The apparent loss of presynaptic Kv3.4 affected the strength of excitatory transmission at the MF-CA3 synapse in hippocampal slices of BACE1-/- mice when probed with the Kv3 channel blocker BDS-I. The effect of BACE1 on Kv3.4 expression and function should be bidirectional, as predicted from a heterologous expression system, in which BACE1 cotransfection produced a concomitant upregulation of Kv3.4 surface level and current based on a physical interaction between the two proteins. Our data show that, by targeting Kv3.4 to presynaptic sites, BACE1 endows the terminal with a powerful means to regulate the strength of transmitter release.SIGNIFICANCE STATEMENT The β-secretase β-site APP-cleaving enzyme 1 (BACE1) is infamous for its crucial role in the pathogenesis of Alzheimer's disease, but its physiological functions in the intact nervous system are only gradually being unveiled. Here, we extend previous work implicating BACE1 in the expression and function of voltage-gated Na+ and K+ channels. Specifically, we characterize voltage-gated K+ channel 3.4 (Kv3.4), a presynaptic K+ channel required for action potential repolarization, as a novel interaction partner of BACE1 at the mossy fiber (MF)-CA3 synapse of the hippocampus. BACE1 promotes surface expression of Kv3.4 at MF terminals, most likely by physically associating with the channel protein in a nonenzymatic fashion. We advance the BACE1-Kv3.4 interaction as a mechanism to strengthen the temporal control over transmitter release from MF terminals.
Copyright © 2018 the authors 0270-6474/18/383481-15$15.00/0.

Entities:  

Keywords:  Alzheimer's disease; BACE1; Kv3; hippocampal mossy fibers; synapse; trafficking

Mesh:

Substances:

Year:  2018        PMID: 29507146      PMCID: PMC5895038          DOI: 10.1523/JNEUROSCI.2643-17.2018

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  68 in total

1.  Up-regulation of the Kv3.4 potassium channel subunit in early stages of Alzheimer's disease.

Authors:  Ester Angulo; Véronique Noé; Vicent Casadó; Josefa Mallol; Teresa Gomez-Isla; Carmen Lluis; Isidre Ferrer; Carlos J Ciudad; Rafael Franco
Journal:  J Neurochem       Date:  2004-11       Impact factor: 5.372

2.  Impaired short-term plasticity in mossy fiber synapses caused by mitochondrial dysfunction of dentate granule cells is the earliest synaptic deficit in a mouse model of Alzheimer's disease.

Authors:  Sang Hun Lee; Kyung-Ran Kim; Shin-Young Ryu; Sungmin Son; Hyun Seok Hong; Inhee Mook-Jung; Suk-Ho Lee; Won-Kyung Ho
Journal:  J Neurosci       Date:  2012-04-25       Impact factor: 6.167

Review 3.  Subcellular localization of K+ channels in mammalian brain neurons: remarkable precision in the midst of extraordinary complexity.

Authors:  James S Trimmer
Journal:  Neuron       Date:  2015-01-21       Impact factor: 17.173

4.  β-Secretase BACE1 regulates hippocampal and reconstituted M-currents in a β-subunit-like fashion.

Authors:  Sabine Hessler; Fang Zheng; Stephanie Hartmann; Andrea Rittger; Sandra Lehnert; Meike Völkel; Matthias Nissen; Elke Edelmann; Paul Saftig; Michael Schwake; Tobias Huth; Christian Alzheimer
Journal:  J Neurosci       Date:  2015-02-25       Impact factor: 6.167

5.  BACE1 deficiency causes altered neuronal activity and neurodegeneration.

Authors:  Xiangyou Hu; Xiangdong Zhou; Wanxia He; Jun Yang; Wencheng Xiong; Philip Wong; Christopher G Wilson; Riqiang Yan
Journal:  J Neurosci       Date:  2010-06-30       Impact factor: 6.167

6.  Reduced sodium channel Na(v)1.1 levels in BACE1-null mice.

Authors:  Doo Yeon Kim; Manuel T Gersbacher; Perrine Inquimbert; Dora M Kovacs
Journal:  J Biol Chem       Date:  2010-12-29       Impact factor: 5.157

7.  Dysregulation of Kv3.4 channels in dorsal root ganglia following spinal cord injury.

Authors:  David M Ritter; Benjamin M Zemel; Tamara J Hala; Michael E O'Leary; Angelo C Lepore; Manuel Covarrubias
Journal:  J Neurosci       Date:  2015-01-21       Impact factor: 6.167

8.  Depletion of GGA3 stabilizes BACE and enhances beta-secretase activity.

Authors:  Giuseppina Tesco; Young Ho Koh; Eugene L Kang; Andrew N Cameron; Shinjita Das; Miguel Sena-Esteves; Mikko Hiltunen; Shao-Hua Yang; Zhenyu Zhong; Yong Shen; James W Simpkins; Rudolph E Tanzi
Journal:  Neuron       Date:  2007-06-07       Impact factor: 17.173

Review 9.  Ion channel regulation by β-secretase BACE1 - enzymatic and non-enzymatic effects beyond Alzheimer's disease.

Authors:  Sandra Lehnert; Stephanie Hartmann; Sabine Hessler; Helmuth Adelsberger; Tobias Huth; Christian Alzheimer
Journal:  Channels (Austin)       Date:  2016-06-02       Impact factor: 2.581

10.  BACE1 inhibition more effectively suppresses initiation than progression of β-amyloid pathology.

Authors:  Finn Peters; Hazal Salihoglu; Eva Rodrigues; Etienne Herzog; Tanja Blume; Severin Filser; Mario Dorostkar; Derya R Shimshek; Nils Brose; Ulf Neumann; Jochen Herms
Journal:  Acta Neuropathol       Date:  2018-01-11       Impact factor: 17.088

View more
  4 in total

Review 1.  The β-secretase (BACE) inhibitor NB-360 in preclinical models: From amyloid-β reduction to downstream disease-relevant effects.

Authors:  Ulf Neumann; Rainer Machauer; Derya R Shimshek
Journal:  Br J Pharmacol       Date:  2019-03-10       Impact factor: 8.739

2.  β-Secretase BACE1 Is Required for Normal Cochlear Function.

Authors:  Marlen Dierich; Stephanie Hartmann; Nadine Dietrich; Philip Moeser; Franziska Brede; Lejo Johnson Chacko; Konstantin Tziridis; Achim Schilling; Patrick Krauss; Sabine Hessler; Sandra Karch; Anneliese Schrott-Fischer; Michael Blumer; Carmen Birchmeier; Dominik Oliver; Tobias Moser; Holger Schulze; Christian Alzheimer; Michael G Leitner; Tobias Huth
Journal:  J Neurosci       Date:  2019-09-16       Impact factor: 6.167

3.  The protective mutation A673T in amyloid precursor protein gene decreases Aβ peptides production for 14 forms of Familial Alzheimer's Disease in SH-SY5Y cells.

Authors:  Antoine Guyon; Joël Rousseau; Gabriel Lamothe; Jacques P Tremblay
Journal:  PLoS One       Date:  2020-12-28       Impact factor: 3.240

4.  Selective reduction of astrocyte apoE3 and apoE4 strongly reduces Aβ accumulation and plaque-related pathology in a mouse model of amyloidosis.

Authors:  Thomas E Mahan; Chao Wang; Xin Bao; Ankit Choudhury; Jason D Ulrich; David M Holtzman
Journal:  Mol Neurodegener       Date:  2022-02-02       Impact factor: 14.195

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.